T2 biosystems, inc. (TTOO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Product revenue

-

-

-

-

599

-

-

-

Research revenue

-

-

-

-

2,214

119

266

-

Revenue:
Total revenue

8,335

10,500

4,666

4,080

-

-

-

-

Total revenue

-

-

-

-

2,813

119

266

19

Costs and expenses:
Cost of product revenue

-

-

-

-

1,740

-

-

-

Research and development

16,326

14,489

23,733

24,009

25,362

19,782

14,936

11,727

Selling, general and administrative

27,304

25,697

22,757

24,077

19,094

11,018

5,022

2,945

Total costs and expenses

60,393

55,590

58,518

54,958

46,196

30,800

19,958

-

Total operating expenses

-

-

-

-

-

-

-

14,672

Loss from operations

-52,058

-45,090

-53,852

-50,878

-43,383

-30,681

-19,692

-14,653

Interest expense, net

-7,348

-6,682

-8,907

-4,098

-1,967

-721

-403

-

Interest expense, net

-

-

-

-

-

-

-

-154

Other income, net

400

619

331

172

60

12

-515

352

Net loss and comprehensive loss

-59,006

-51,153

-62,428

-54,804

-45,290

-31,390

-20,610

-14,455

Comprehensive loss

-

-

-

-

-

-31,390

-

-14,455

Net loss

-59,006

-51,153

-62,428

-54,804

-45,290

-

-

-14,455

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

4,570

6,908

4,412

Net loss applicable to common stockholders

-

-

-

-

-

-35,960

-27,518

-18,867

Net loss per share — basic and diluted

-1.30

-1.26

-1.94

-2.11

-2.21

-4.15

-19.72

-13.86

Weighted-average number of common shares used in computing net loss per share — basic and diluted

45,507

40,558

32,131

26,015

20,501

8,674

1,395

1,361

Product [Member]
Total revenue

5,327

4,805

3,440

1,747

-

-

-

-

Cost of product revenue

16,763

15,404

12,028

6,872

-

-

-

-

Research [Member]
Total revenue

563

5,695

1,226

2,333

-

-

-

-

Contribution [Member]
Total revenue

2,445

-

-

-

-

-

-

-